期刊文献+

结肠癌干细胞标志物和信号通路的研究进展 被引量:7

Advances in research on stem cell markers and signaling pathways in colon cancer
原文传递
导出
摘要 结肠癌是一种最常见的消化道恶性肿瘤,世界范围内其发病率位列第三。大部分的结肠癌患者死亡由肿瘤的复发转移和耐药性所致,而这些过程都有肿瘤干细胞的参与。因此,靶向肿瘤干细胞将成为未来根治结肠癌的重要研究方向,而结肠癌干细胞标志物的发现则为其提供了新思路。同时,因结肠癌干细胞的生长依赖多种信号通路的作用,故其相关信号通路靶向药物的研究也将是一大发展方向。该文就目前关于结肠癌干细胞标志物及其相关信号通路抑制剂的研究进展作一综述。 Colon cancer is one of the most common malignant tumors of the digestive tract,and its incidence ranks third in the world.Most patients with colon cancer die of tumor recurrence and metastasis as well as drug resistance,which are related to cancer stem cells.Therefore,targeting cancer stem cells will become an important research direction for radical cure of colon cancer in the future,and the discovery of colon cancer stem cell markers opens a new window for it.Moreover,since the growth of colon cancer stem cells depends on various signaling pathways,the research on targeted drugs of colon cancer stem cell-related signaling pathways will also be a major development direction.In this paper,the current research progress on cancer stem cell markers and inhibitors of related signaling pathway in colon cancer is reviewed.
作者 张子怡 林泉任 叶春雨 金燕 ZHANG Zi-Yi;LIN Quan-Ren;YE Chun-Yu;JIN Yan(College of Medicine,Yanbian University,Yanji 133002,China;Department of Cell Biology and Medical Genetics,College of Medicine,Yanbian University,Yanji 133002,China)
出处 《生命科学》 CSCD 北大核心 2019年第8期802-811,共10页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(81660494)
关键词 结肠癌干细胞 生物学标志物 信号通路 肿瘤转移 抑制剂 colon cancer stem cells biomarkers signaling pathway tumor metastasis inhibitor
  • 相关文献

参考文献10

二级参考文献116

  • 1庄建良,苏子剑,许荣誉.活化白细胞黏附分子及其与肿瘤侵袭转移的关系[J].国际病理科学与临床杂志,2006,26(6):479-482. 被引量:6
  • 2Ayala I, Baldassarre M, Giacchetti G, et al. Muhiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellu|ar matrix degradation [J]. J Cell Sci, 2008,121 (Pt 3) :369-378 .
  • 3Swart G W. Activated leukocyte cell adhesion molecule(CD166/ ALCAM):Developmental and mechanistic aspects of cell clustering and cell migration [J]. Eur J Cell Biot, 2002,81(6): 313-321.
  • 4Schwab M, Scott A. Weed. Encyclopedia of Cancer [M]. NewYork: Springer-Verlag Berlin Heidelberg, 2008.
  • 5Burkhardt, Mayordomo E, Winzer K J, et al. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer [J]. J Clin Pathol, 2006,Apt,59(4):403-409.
  • 6Ishigami S, Ueno S, Arigami T, et al. Clinical implication of CD166 expression in gastric cancer [J]. J Surg Oncol, 2011, 103(1) :57-61.
  • 7Weichert W, Knosel T, Bellach J, et al. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival [J]. J Clin Pathol, 2004,57(11): 1160-1164.
  • 8Wiiger M T, Gehrken H B, Fodstad O, et al. A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth [J]. Cancer Immunol Immunother, 2010,59( 11 ) : 1665-1674.
  • 9Pece S,Tosoni D, Confalonieri S ,et al. Biological and molecular het-erogeneity of breast cancers correlates with their cancer stem cellcontent [J]. Cell ,2010,140:62-73.
  • 10Wright MH,Calcagno AM,Salcido CD,et al. Brcal breast tumorscontain distinct CD44VCD24' and CD133 + cells with cancer stemcell characteristics [J]. Breast Cancer Res, 2008,10:RIO.

共引文献59

同被引文献51

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部